Introduction: emerging role of epigenetic therapy: focus on decitabine.
Issa
Jean-Pierre J
JP
Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Kantarjian
Hagop M
HM
D001374:Azacitidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors; D000077209:Decitabine; D044127:Epigenesis, Genetic / Q000187:drug effects*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D000077209:Decitabine; D015254:DNA Modification Methylases; D001374:Azacitidine